Suppr超能文献

吸烟者尼古丁代谢比值的可重复性。

Reproducibility of the nicotine metabolite ratio in cigarette smokers.

机构信息

Center for Tobacco Control Research and Education, University of California, San Francisco, San Francisco, CA 94143, USA.

出版信息

Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1105-14. doi: 10.1158/1055-9965.EPI-12-0236. Epub 2012 May 2.

Abstract

BACKGROUND

The nicotine metabolite ratio (NMR or 3-hydroxycotinine/cotinine) has been used to phenotype CYP2A6-mediated nicotine metabolism. Our objectives were to analyze (i) the stability of NMR in plasma, saliva, and blood in various storage conditions, (ii) the relationship between NMRs derived from blood, plasma, saliva, and urine, and (iii) the reproducibility of plasma NMR in ad libitum cigarette smokers.

METHODS

We analyzed data from four clinical studies. In studies 1 and 2, we assessed NMR stability in saliva and plasma samples at room temperature (~22°C) over 14 days and in blood at 4°C for up to 72 hours. In studies 2 and 3, we used Bland-Altman analysis to assess agreement between blood, plasma, saliva, and urine NMRs. In study 4, plasma NMR was measured on six occasions over 44 weeks in 43 ad libitum smokers.

RESULTS

Reliability coefficients for stability tests of NMR in plasma and saliva at room temperature were 0.97 and 0.98, respectively, and 0.92 for blood at 4°C. Blood NMR agreed consistently with saliva and plasma NMRs but showed more variability in relation to urine NMR. The reliability coefficient for repeated plasma NMR measurements in smokers was 0.85.

CONCLUSION

The NMR is stable in blood, plasma, and saliva at the conditions tested. Blood, plasma, and saliva NMRs are similar whereas urine NMR is a good proxy for these NMR measures. Plasma NMR was reproducible over time in smokers.

IMPACT

One measurement may reliably estimate a smoker's NMR for use as an estimate of the rate of nicotine metabolism.

摘要

背景

尼古丁代谢物比(NMR 或 3-羟基可替宁/可铁宁)已被用于表型 CYP2A6 介导的尼古丁代谢。我们的目的是分析:(i)在各种储存条件下,NMR 在血浆、唾液和血液中的稳定性;(ii)源自血液、血浆、唾液和尿液的 NMR 之间的关系;(iii)随意吸烟的吸烟者中血浆 NMR 的重现性。

方法

我们分析了四项临床研究的数据。在研究 1 和 2 中,我们评估了室温(~22°C)下唾液和血浆样本中 NMR 的稳定性,以及 4°C 下血液中长达 72 小时的稳定性。在研究 2 和 3 中,我们使用 Bland-Altman 分析来评估血液、血浆、唾液和尿液 NMR 之间的一致性。在研究 4 中,43 名随意吸烟者在 44 周内进行了 6 次血浆 NMR 测量。

结果

室温下血浆和唾液中 NMR 稳定性测试的可靠性系数分别为 0.97 和 0.98,4°C 下血液中的可靠性系数为 0.92。血液 NMR 与唾液和血浆 NMR 一致,但与尿液 NMR 的变异性更大。吸烟者重复测量血浆 NMR 的可靠性系数为 0.85。

结论

在测试条件下,NMR 在血液、血浆和唾液中稳定。血液、血浆和唾液 NMR 相似,而尿液 NMR 是这些 NMR 测量的良好替代物。在吸烟者中,血浆 NMR 随时间具有可重复性。

意义

一次测量可能可以可靠地估计吸烟者的 NMR,作为尼古丁代谢率的估计。

相似文献

1
Reproducibility of the nicotine metabolite ratio in cigarette smokers.
Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1105-14. doi: 10.1158/1055-9965.EPI-12-0236. Epub 2012 May 2.
2
Stability of the nicotine metabolite ratio in smokers of progressively reduced nicotine content cigarettes.
Nicotine Tob Res. 2013 Nov;15(11):1939-42. doi: 10.1093/ntr/ntt065. Epub 2013 May 14.
3
Variation in trans-3'-hydroxycotinine glucuronidation does not alter the nicotine metabolite ratio or nicotine intake.
PLoS One. 2013 Aug 2;8(8):e70938. doi: 10.1371/journal.pone.0070938. Print 2013.
4
Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity.
Clin Pharmacol Ther. 2004 Jul;76(1):64-72. doi: 10.1016/j.clpt.2004.02.011.
5
Prediction methods for nicotine clearance using cotinine and 3-hydroxy-cotinine spot saliva samples II. Model application.
J Pharmacokinet Pharmacodyn. 2007 Feb;34(1):23-34. doi: 10.1007/s10928-006-9026-0. Epub 2007 Jan 6.
6
Nicotine Metabolism in Young Adult Daily Menthol and Nonmenthol Smokers.
Nicotine Tob Res. 2016 Apr;18(4):437-46. doi: 10.1093/ntr/ntv109. Epub 2015 May 19.
7
Nicotine metabolite ratio (3-hydroxycotinine/cotinine) in plasma and urine by different analytical methods and laboratories: implications for clinical implementation.
Cancer Epidemiol Biomarkers Prev. 2015 Aug;24(8):1239-46. doi: 10.1158/1055-9965.EPI-14-1381. Epub 2015 May 26.
10
Nicotine metabolite ratio: Comparison of the three urinary versions to the plasma version and nicotine clearance in three clinical studies.
Drug Alcohol Depend. 2021 Jun 1;223:108708. doi: 10.1016/j.drugalcdep.2021.108708. Epub 2021 Apr 20.

引用本文的文献

1
Sex-specific relations of ceramides and white matter hyperintensities in the Rhineland study.
Sci Rep. 2025 Jul 3;15(1):23757. doi: 10.1038/s41598-025-06911-z.
3
PharmVar GeneFocus: CYP2A6.
Clin Pharmacol Ther. 2024 Oct;116(4):948-962. doi: 10.1002/cpt.3387. Epub 2024 Jul 25.
5
The lipidomic correlates of epigenetic aging across the adult lifespan: A population-based study.
Aging Cell. 2023 Sep;22(9):e13934. doi: 10.1111/acel.13934. Epub 2023 Jul 26.
6
The use of biomarkers to guide precision treatment for tobacco use.
Addict Neurosci. 2023 Jun;6. doi: 10.1016/j.addicn.2023.100076. Epub 2023 Feb 16.
8
Impact of Genetic Variants in the Nicotine Metabolism Pathway on Nicotine Metabolite Levels in Smokers.
Cancer Epidemiol Biomarkers Prev. 2023 Jan 9;32(1):54-65. doi: 10.1158/1055-9965.EPI-22-0868.
9
Predicting nicotine metabolism across ancestries using genotypes.
BMC Genomics. 2022 Sep 21;23(1):663. doi: 10.1186/s12864-022-08884-z.

本文引用的文献

1
Smoking behavior and exposure to tobacco toxicants during 6 months of smoking progressively reduced nicotine content cigarettes.
Cancer Epidemiol Biomarkers Prev. 2012 May;21(5):761-9. doi: 10.1158/1055-9965.EPI-11-0644. Epub 2012 Feb 21.
2
Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk.
J Natl Cancer Inst. 2011 Sep 7;103(17):1342-6. doi: 10.1093/jnci/djr237. Epub 2011 Jul 11.
3
Systematic review of the relationship between the 3-hydroxycotinine/cotinine ratio and cigarette dependence.
Psychopharmacology (Berl). 2011 Nov;218(2):313-22. doi: 10.1007/s00213-011-2341-1. Epub 2011 May 20.
4
Nicotine metabolite ratio predicts smoking topography and carcinogen biomarker level.
Cancer Epidemiol Biomarkers Prev. 2011 Feb;20(2):234-8. doi: 10.1158/1055-9965.EPI-10-0674. Epub 2011 Jan 6.
6
New CYP2A6 gene deletion and conversion variants in a population of Black African descent.
Pharmacogenomics. 2010 Feb;11(2):189-98. doi: 10.2217/pgs.09.144.
7
A link between adolescent nicotine metabolism and smoking topography.
Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1578-83. doi: 10.1158/1055-9965.EPI-08-0592.
8
Association of nicotine metabolite ratio and CYP2A6 genotype with smoking cessation treatment in African-American light smokers.
Clin Pharmacol Ther. 2009 Jun;85(6):635-43. doi: 10.1038/clpt.2009.19. Epub 2009 Mar 11.
9
Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymes.
J Neurogenet. 2009;23(3):252-61. doi: 10.1080/01677060802572887. Epub 2009 Jan 23.
10
Nicotine metabolism in three ethnic/racial groups with different risks of lung cancer.
Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3526-35. doi: 10.1158/1055-9965.EPI-08-0424. Epub 2008 Nov 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验